P. Karageorgis

1.0k total citations
18 papers, 789 citations indexed

About

P. Karageorgis is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, P. Karageorgis has authored 18 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Genetics. Recurrent topics in P. Karageorgis's work include Brain Metastases and Treatment (7 papers), Effects of Radiation Exposure (7 papers) and Glioma Diagnosis and Treatment (6 papers). P. Karageorgis is often cited by papers focused on Brain Metastases and Treatment (7 papers), Effects of Radiation Exposure (7 papers) and Glioma Diagnosis and Treatment (6 papers). P. Karageorgis collaborates with scholars based in Greece. P. Karageorgis's co-authors include D. Antonadou, N. Throuvalas, N. Coliarakis, M. Synodinou, M. Paraskevaidis, George E. Sarris, I. Economou, H. Athanassiou, K. Beroukas and Despina Misailidou and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

P. Karageorgis

16 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Karageorgis Greece	7	572	370	305	209	99	18	789
M. Synodinou Greece	10	519 0.9×	220 0.6×	179 0.6×	354 1.7×	155 1.6×	24	844
B. Parashar United States	17	420 0.7×	184 0.5×	179 0.6×	173 0.8×	152 1.5×	47	876
Wee Yao Koh Singapore	10	500 0.9×	260 0.7×	240 0.8×	82 0.4×	45 0.5×	22	662
Rovel Colaco United Kingdom	13	327 0.6×	144 0.4×	279 0.9×	61 0.3×	72 0.7×	33	582
Amanda Schwer United States	8	828 1.4×	407 1.1×	528 1.7×	62 0.3×	40 0.4×	15	962
Serap Akyürek Türkiye	12	194 0.3×	299 0.8×	135 0.4×	145 0.7×	41 0.4×	50	623
Horst Sack Germany	17	219 0.4×	102 0.3×	148 0.5×	198 0.9×	111 1.1×	38	735
H. Athanassiou Greece	4	229 0.4×	179 0.5×	132 0.4×	109 0.5×	46 0.5×	8	512
Emily S. Lebow United States	12	380 0.7×	107 0.3×	378 1.2×	60 0.3×	50 0.5×	33	586
Sei‐Chul Yoon South Korea	15	200 0.3×	85 0.2×	204 0.7×	124 0.6×	109 1.1×	25	619

Countries citing papers authored by P. Karageorgis

Since Specialization

Citations

This map shows the geographic impact of P. Karageorgis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Karageorgis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Karageorgis more than expected).

Fields of papers citing papers by P. Karageorgis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Karageorgis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Karageorgis. The network helps show where P. Karageorgis may publish in the future.

Co-authorship network of co-authors of P. Karageorgis

This figure shows the co-authorship network connecting the top 25 collaborators of P. Karageorgis. A scholar is included among the top collaborators of P. Karageorgis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Karageorgis. P. Karageorgis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ziras, Nikolaos, Pelagia Tsoutsou, George E. Sarris, et al.. (2012). Phase I study of postoperative radiotherapy with concomitant weekly irinotecan, 5- fluorouracil and folinic acid in locally advanced rectal cancer.. PubMed. 9(3). 255–61.

Paraskevaidis, M., et al.. (2008). Radiation dermatitis: implicated factors, clinical aspects, possible prevention, and medical care.. PubMed. 12(4). 463–70. 4 indexed citations

Athanassiou, H., M. Synodinou, Despina Misailidou, et al.. (2005). Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma Multiforme. Journal of Clinical Oncology. 23(10). 2372–2377. 212 indexed citations

Antonadou, D., N. Coliarakis, Vasileios Papadopoulos, et al.. (2005). A Multicenter, Open Study Evaluating the Impact of Darbepoetin Alfa on Anaemia and Quality of Life, in Cancer Patients Undergoing Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 63. S82–S83. 2 indexed citations

Athanassiou, H., M. Synodinou, M. Paraskevaidis, et al.. (2004). Combination of temozolomide (TMZ) and radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase II study. International Journal of Radiation Oncology*Biology*Physics. 60(1). S162–S163. 2 indexed citations

Antonadou, D., H. Athanassiou, M. Synodinou, et al.. (2004). Final results of a randomized phase III trial of chemoradiation treatment + amifostine in patients with colorectal cancer: Clinical radiation oncology hellenic group. International Journal of Radiation Oncology*Biology*Physics. 60(1). S140–S141. 3 indexed citations

Athanassiou, H., D. Antonadou, N. Coliarakis, et al.. (2003). Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: Results of a randomized trial. International Journal of Radiation Oncology*Biology*Physics. 56(4). 1154–1160. 79 indexed citations

Antonadou, D., N. Coliarakis, M. Paraskevaidis, et al.. (2003). 777 A multi-institutional trial comparing survival of patients with brain metastases from lung cancer treated with temozolomide plus radiotherapy versus radiotherapy alone. European Journal of Cancer Supplements. 1(5). S234–S234. 3 indexed citations

Antonadou, D., H. Athanassiou, George E. Sarris, et al.. (2003). 1087 Randomized phase III trial of chemoradiation treatment amifostine in patients with colorectal cancer. European Journal of Cancer Supplements. 1(5). S325–S325. 1 indexed citations

10.

Athanassiou, H., M. Synodinou, M. Paraskevaidis, et al.. (2003). 311 Temozolomide (TMZ) combined with radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase III study. European Journal of Cancer Supplements. 1(5). S95–S96. 2 indexed citations

11.

Antonadou, D., et al.. (2003). O-67 A multi-institutional trial comparing survival of patients with brain metastases from lung cancer treated with temozolomide plus radiotherapy versus to radiotherapy alone. Lung Cancer. 41. S22–S23. 14 indexed citations

12.

Antonadou, D., N. Coliarakis, M. Paraskevaidis, et al.. (2002). Whole brain radiotherapy alone or in combination with temozolomide for brain metastases. a phase III study. International Journal of Radiation Oncology*Biology*Physics. 54(2). 93–94. 37 indexed citations

13.

Antonadou, D., M. Paraskevaidis, George E. Sarris, et al.. (2002). Phase II Randomized Trial of Temozolomide and Concurrent Radiotherapy in Patients With Brain Metastases. Journal of Clinical Oncology. 20(17). 3644–3650. 254 indexed citations

14.

Antonadou, D., et al.. (2001). Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer. International Journal of Radiation Oncology*Biology*Physics. 51(4). 915–922. 154 indexed citations

15.

Antonadou, D., et al.. (2001). Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. European Journal of Cancer. 37. S358–S358. 2 indexed citations

16.

Antonadou, D., et al.. (1999). Effect of amifostine on toxicities associated with induction chemotherapy and radiotherapy for head and neck and lung cancer. European Journal of Cancer. 35. S377–S377.

17.

Antonadou, D., N. Coliarakis, M. Synodinou, et al.. (1999). 18 Randomized phase III trial of radiation ± amifostine in patients with advanced stage lung cancer. International Journal of Radiation Oncology*Biology*Physics. 45(3). 154–154. 18 indexed citations

18.

Karageorgis, P., et al.. (1982). Contribution of the hyperdynamic radiotherapy in the treatment of the nasopharynx tumors.. PubMed. 158(3). 156–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact